The Effects of Atorvastatin Treatment in COPD Patients

Trial Profile

The Effects of Atorvastatin Treatment in COPD Patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Feb 2015

At a glance

  • Drugs Atorvastatin (Primary) ; Formoterol
  • Indications Chronic obstructive pulmonary disease
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 01 Apr 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 14 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top